These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 20514398)
1. A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay. Chen H; Wang CS; Li M; Sanchez E; Li J; Berenson A; Wirtschafter E; Wang J; Shen J; Li Z; Bonavida B; Berenson JR Int J Oncol; 2010 Jul; 37(1):71-9. PubMed ID: 20514398 [TBL] [Abstract][Full Text] [Related]
2. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents. As MN; Deshpande R; Kale VP; Bhonde RR; Datar SP Cell Biol Int; 2018 Nov; 42(11):1474-1483. PubMed ID: 30136736 [TBL] [Abstract][Full Text] [Related]
3. Development of collateral vessels: A new paradigm in CAM angiogenesis model. Gatne DP; Mungekar S; Addepalli V; Mohanraj K; Ghone SA; Rege NN Microvasc Res; 2016 Jan; 103():11-3. PubMed ID: 26390964 [TBL] [Abstract][Full Text] [Related]
5. Assessment of angiogenic properties of biomaterials using the chicken embryo chorioallantoic membrane assay. Azzarello J; Ihnat MA; Kropp BP; Warnke LA; Lin HK Biomed Mater; 2007 Jun; 2(2):55-61. PubMed ID: 18458436 [TBL] [Abstract][Full Text] [Related]
6. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib. Özcetin A; Aigner A; Bakowsky U Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770 [TBL] [Abstract][Full Text] [Related]
7. The chick chorioallantoic membrane as an in vivo angiogenesis model. Ponce ML; Kleinmann HK Curr Protoc Cell Biol; 2003 May; Chapter 19():Unit 19.5. PubMed ID: 18228425 [TBL] [Abstract][Full Text] [Related]
8. Generation of bioengineered feather buds on a reconstructed chick skin from dissociated epithelial and mesenchymal cells. Ishida K; Mitsui T Dev Growth Differ; 2016 Apr; 58(3):303-14. PubMed ID: 27019985 [TBL] [Abstract][Full Text] [Related]
9. The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo. Strese S; Wickström M; Fuchs PF; Fryknäs M; Gerwins P; Dale T; Larsson R; Gullbo J Biochem Pharmacol; 2013 Oct; 86(7):888-95. PubMed ID: 23933387 [TBL] [Abstract][Full Text] [Related]
10. The use of the chick embryo CAM assay in the study of angiogenic activiy of biomaterials. Ribatti D; Annese T; Tamma R Microvasc Res; 2020 Sep; 131():104026. PubMed ID: 32505611 [TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic activity of azathioprine. de Melo Bisneto AV; Fernandes AS; Velozo Sá VS; Véras JH; Soares ETS; da Silva Santos AF; Cardoso CG; Silveira-Lacerda EP; Carneiro CC; Chen-Chen L Microvasc Res; 2021 Nov; 138():104234. PubMed ID: 34478745 [TBL] [Abstract][Full Text] [Related]
12. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells. Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633 [TBL] [Abstract][Full Text] [Related]
13. Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis. Ribatti D Int Rev Cell Mol Biol; 2008; 270():181-224. PubMed ID: 19081537 [TBL] [Abstract][Full Text] [Related]
14. A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays. Gnutti A; Signoroni A; Leonardi R; Corsini M; Presta M; Mitola S Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():763-6. PubMed ID: 26736374 [TBL] [Abstract][Full Text] [Related]
15. A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances. Hazel SJ J Lab Clin Med; 2003 Mar; 141(3):217-28. PubMed ID: 12624603 [TBL] [Abstract][Full Text] [Related]
16. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents. Tufan AC; Satiroglu-Tufan NL Curr Cancer Drug Targets; 2005 Jun; 5(4):249-66. PubMed ID: 15975046 [TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of vascular colonisation and angio-conduction in porous silicon-substituted hydroxyapatite with various pore shapes in a chick chorioallantoic membrane (CAM) model. Magnaudeix A; Usseglio J; Lasgorceix M; Lalloue F; Damia C; Brie J; Pascaud-Mathieu P; Champion E Acta Biomater; 2016 Jul; 38():179-89. PubMed ID: 27131570 [TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic and anti-cancer evaluation of betulin nanoemulsion in chicken chorioallantoic membrane and skin carcinoma in Balb/c mice. Dehelean CA; Feflea S; Gheorgheosu D; Ganta S; Cimpean AM; Muntean D; Amiji MM J Biomed Nanotechnol; 2013 Apr; 9(4):577-89. PubMed ID: 23621016 [TBL] [Abstract][Full Text] [Related]
19. Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model. Nowak-Sliwinska P; Ballini JP; Wagnières G; van den Bergh H Microvasc Res; 2010 Jan; 79(1):21-8. PubMed ID: 19857502 [TBL] [Abstract][Full Text] [Related]